Shortage of Propranolol Hydrochloride Injection

Drug Shortages medium FDA · · United States

The FDA has reported a current shortage of Propranolol Hydrochloride Injection, a cardiovascular medication, with details on availability from manufacturers.

What's in Shortage

Propranolol Hydrochloride Injection (generic name) and PROPRANOLOL (brand name) in injection dosage form is currently in shortage. It belongs to the cardiovascular therapeutic category. The shortage was first posted on 10/31/2023 and last updated on 04/02/2026.

Which Manufacturers Are Affected

Fresenius Kabi USA, LLC: Availability status is available. Related info: Check wholesalers for inventory. Presentation: Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01). Contact info: 888-386-1300.

Why There's a Shortage

No specific reason was given for the shortage.

What Patients Should Do

Patients should talk to their pharmacist about the availability of this medication and ask about possible alternatives. They may also contact the manufacturer directly. Patients should consult their healthcare provider for any medical advice and not make changes to their treatment without professional guidance.

Source

Information is from the FDA Drug Shortage Database.

Source: FDA Official Notice

Frequently Asked Questions

What is this drug shortages alert about?
The FDA has reported a current shortage of Propranolol Hydrochloride Injection, a cardiovascular medication, with details on availability from manufacturers.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more drug shortages alerts?
Browse all drug shortages alerts on Areazine at areazine.com/drug-shortages/ for the latest updates from FDA and other agencies.